| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb5d71aec734216a087194e26ea2bcd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_994ca53de5d68c569cf4adef372c0c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85e3c60b6d22ce7030331b6b67dcb6b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate |
2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead40dbb6ca7d57a1bc16b426f1517ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2450fc57e3284e5eeca5da5d07b104a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9f8aff5fd8d3c0233b3f9d33542223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fffe435ec1c0e8b9f4d0153fd648f0ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e38ad75b7e0a9e023e828148533f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3c93230a1f14395a20c64d8e0cadb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da51917effd280dcbd4cb9946b765a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36bab3fef5c6228c8f1f3dec5ee5cf52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9ead889d091db2c8b74ae0a8a93ddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb40fb20161654572bc005cc461f734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937823607726e96731350a90a981b4ee |
| publicationDate |
2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2927230-B1 |
| titleOfInvention |
Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy |
| priorityDate |
2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |